Halper Sadeh LLP announced investigation into whether the Sale of Medidata solutions are fair to shareholders
- On behalf of Medidata shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.
**Note On April 30, 2019, Piper Jaffray Companies set a target price for Medidata at $96.00 per share. The Medidata merger investigation concerns whether Medidata and its Board of Directors violated the federal securities laws and/or their fiduciary duties to shareholders by failing to: (1) obtain the best possible price for Medidata shareholders; (2) determine whether Dassault is underpaying for Medidata; and (3) disclose all material information necessary for Medidata shareholders to adequately assess and value the merger consideration.